Zhao H W, Gu X Q, Chailangkarn T, Perkins G, Callacondo D, Appenzeller O, Poulsen O, Zhou D, Muotri A R, Haddad G G
Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA.
Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
Neuroscience. 2015 Mar 12;288:187-99. doi: 10.1016/j.neuroscience.2014.12.039. Epub 2015 Jan 3.
Monge's disease, also known as chronic mountain sickness (CMS), is a disease that potentially threatens more than 140 million highlanders during extended time living at high altitudes (over 2500m). The prevalence of CMS in Andeans is about 15-20%, suggesting that the majority of highlanders (non-CMS) are rather healthy at high altitudes; however, CMS subjects experience severe hypoxemia, erythrocytosis and many neurologic manifestations including migraine, headache, mental fatigue, confusion, and memory loss. The underlying mechanisms of CMS neuropathology are not well understood and no ideal treatment is available to prevent or cure CMS, except for phlebotomy. In the current study, we reprogrammed fibroblast cells from both CMS and non-CMS subjects' skin biopsies into the induced pluripotent stem cells (iPSCs), then differentiated into neurons and compared their neuronal properties. We discovered that CMS neurons were much less excitable (higher rheobase) than non-CMS neurons. This decreased excitability was not caused by differences in passive neuronal properties, but instead by a significantly lowered Na(+) channel current density and by a shift of the voltage-conductance curve in the depolarization direction. Our findings provide, for the first time, evidence of a neuronal abnormality in CMS subjects as compared to non-CMS subjects, hoping that such studies can pave the way to a better understanding of the neuropathology in CMS.
蒙赫氏病,也称为慢性高山病(CMS),是一种在长期居住于高海拔地区(超过2500米)时可能威胁超过1.4亿高原居民的疾病。CMS在安第斯人群中的患病率约为15%至20%,这表明大多数高原居民(非CMS患者)在高海拔地区相当健康;然而,CMS患者会经历严重的低氧血症、红细胞增多症以及许多神经学表现,包括偏头痛、头痛、精神疲劳、意识模糊和记忆力减退。CMS神经病理学的潜在机制尚未完全了解,除了放血疗法外,没有理想的治疗方法来预防或治愈CMS。在本研究中,我们将CMS患者和非CMS患者皮肤活检的成纤维细胞重编程为诱导多能干细胞(iPSC),然后分化为神经元并比较它们的神经元特性。我们发现,CMS神经元的兴奋性比非CMS神经元低得多(基强度更高)。这种兴奋性降低不是由神经元被动特性的差异引起的,而是由Na(+)通道电流密度显著降低以及电压-电导曲线在去极化方向上的偏移引起的。我们的研究结果首次提供了与非CMS患者相比,CMS患者存在神经元异常的证据,希望此类研究能够为更好地理解CMS的神经病理学铺平道路。